Platelet Mitochondrial Dysfunction is Evident in Type 2 Diabetes in Association with Modifications of Mitochondrial Anti-Oxidant Stress Proteins
- 15 September 2011
- journal article
- research article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 120 (04), 248-251
- https://doi.org/10.1055/s-0031-1285833
Abstract
Mitochondrial dysfunction and oxidative stress in insulin responsive tissues is implicated in the pathogenesis of type 2 diabetes. Whether these perturbations extend to other tissues and contribute to their pathophysiology is less well established. The objective of this study was to investigate platelet mitochondria to evaluate whether type 2 diabetes associated mitochondrial dysfunction is evident in circulating cells. A pilot study of mitochondrial respiratory function and proteomic changes comparing platelets extracted from insulin sensitive (n=8) and type 2 diabetic subjects (n=7). In-situ platelet mitochondria show diminished oxygen consumption and lower oxygen-dependent ATP synthesis in diabetic vs. control subjects. Mass spectrometric identification and confirmatory immunoblot analysis identifies induction of the mitochondrial anti-oxidant enzymes superoxide dismutase 2 and thioredoxin-dependent peroxide reductase 3 in platelets of diabetic subjects. As oxidative stress upregulates anti-oxidant enzymes we assessed mitochondrial protein carbonylation as an index of oxidative-stress. Platelets of diabetic subjects exhibit significantly increased protein carbonylation compared to controls. As platelets are anuclear fragments of megakaryocytes, our data suggest that the bone marrow compartment in type 2 diabetic subjects is exposed to increased mitochondrial oxidative stress with upregulation of nuclear-encoded antioxidant mitochondrial enzymes. This ‘stress-signature’ in platelets of diabetic subjects is associated with a diminution of their mitochondrial contribution to energy production and support that mitochondrial perturbations in type 2 diabetes extends beyond the classical insulin responsive tissues. Platelets, as “accessible human tissue”, may be useful to measure the mitochondrial modulatory effects of emerging anti-diabetic therapeutics. * Contributed equally to this studyKeywords
This publication has 15 references indexed in Scilit:
- Cardioprotection leads to novel changes in the mitochondrial proteomeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin ResistanceEndocrine Reviews, 2009
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Isolation and Subfractionation of Mitochondria from Animal Cells and Tissue Culture LinesMethods in Cell Biology, 2007
- Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cellsAmerican Journal of Physiology-Cell Physiology, 2007
- Mitochondrial Matrix Phosphoproteome: Effect of Extra Mitochondrial CalciumBiochemistry, 2006
- Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of κB-α phosphorylation and nuclear factor-κB activationJournal of Endocrinology, 2005
- Mitochondrial Dysfunction and Type 2 DiabetesScience, 2005
- A Possible Link Between Skeletal Muscle Mitochondrial Efficiency and Age-Induced Insulin ResistanceDiabetes, 2004
- Transcriptional regulatory circuits controlling mitochondrial biogenesis and functionGenes & Development, 2004